$155.00
KLOW
BPC-157 + TB-500 + GHK-Cu + KPV
Contents: BPC-157 (10 mg) + TB-500 (10 mg) + GHK-Cu (50 mg) + KPV (10mg)
Form: Lyophilized Powder
Purity: ≥ 99% pure
Emerging Research Evidence:
Accelerates wound & tissue repair, anti-inflammatory properties, promotes skin rejuvenation, stimulates collagen production, anti-aging, improved gut health and eases the symptoms of IBS.
Keep product in cool, dark place.
Sold for Research Use Only / Not FDA Regulated
In stock
KLOW Overview
KLOW is a vendor-defined 4-peptide research blend—GHK-Cu + BPC-157 + TB-500 + KPV. It’s marketed to study multi-pathway tissue repair, inflammation control, skin vitality, and gut/immune signaling. Combining peptides that support collagen production, boost cell turnover, enhance microcirculation and improve gut health, KLOW helps restore a youthful glow and addresses common issues like dullness, hyperpigmentation, and fine lines. Research is showing this all-in-one blend potentially supports tissue healing, cellular repair, collagen synthesis, gut health and powerful anti-inflammatory effects. If you’re recovering from surgery, managing chronic pain, have IBD or simply want to promote healthier skin and connective tissue, KLOW is showing promising results. Research is ongoing and the claimed benefits are still emerging.
KLOW Structure:
1) BPC-157 (a 15-aa “Body Protection Compound” fragment)
Synonyms: Bepecin; PL-14736; GEPPPGKPADDAGLV; “Gastric pentadecapeptide BPC-157.”
Research Areas: Tendon/ligament and soft-tissue healing, cytoprotection, anti-inflammation (pre-clinical).
2) TB-500 (N-acetyl-LKKTETQ, a thymosin-β4 fragment 17–23)
Synonyms: Thymosin-β4 fragment (17–23); Ac-LKKTETQ
Research Areas: Actin-binding/migration pathways, angiogenesis, soft-tissue repair (pre-clinical; also monitored in anti-doping research)
3) GHK-Cu (copper(II) complex of Gly-His-Lys)
Synonyms: Copper tripeptide-1 (INCI); Cu-GHK; Prezatide copper
Research Areas: Dermal repair/collagen synthesis, anti-inflammatory/antioxidant signaling, hair and skin aging biology (pre-clinical & cosmetic science)
4) KPV (α-MSH 11–13)
Synonyms: Lys-Pro-Val, α-MSH(11-13)
Research areas: anti-inflammatory signaling, mucosal/barrier models, antimicrobial activity (preclinical)
KLOW Research Areas:
Research-only note: KLOW is not FDA-approved for therapeutic use; published effects are primarily preclinical and exploratory.
For Research Use Only — Not for Human or Veterinary Use. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. All information on this website is provided strictly for laboratory research and educational purposes. Nothing herein constitutes medical, clinical, or legal advice, nor an endorsement of non-laboratory use. Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.